Thomas P Burris
Affiliations: | Scripps Research Institute, La Jolla, La Jolla, CA, United States | ||
| Washington University, Saint Louis, St. Louis, MO |
Area:
Molecular BiologyWebsite:
http://clinicalpharmstl.org/research/Burris.htmlGoogle:
"Thomas Patrick Burris" OR "Thomas P Burris"Bio:
Parents
Sign in to add mentor| Marc E. Freeman | grad student | 1993 | Florida State (Neurotree) | |
| (Dopaminergic stimulation of prolactin secretion from the anterior pituitary gland) | ||||
| Edward R. B. McCabe | post-doc | UCLA School of Medicine | ||
| Bert W. O'Malley | post-doc | Baylor College of Medicine (Neurotree) | ||
Children
Sign in to add trainee| Christine A. Crumbley | grad student | 2012 | Scripps Institute |
| Kristine Griffett | post-doc | Scripps Research Institute | |
| Douglas J. Kojetin | post-doc | 2009-2010 | Scripps Research Institute (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Burris TP, de Vera IMS, Cote I, et al. (2023) . Pharmacological Reviews |
| Hampton CS, Sitaula S, Billon C, et al. (2023) Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915. European Journal of Medicinal Chemistry. 258: 115582 |
| Makhija S, Griffett JD, Veerakanellore GB, et al. (2023) REV-ERB activation as a novel pharmacological approach for treating inflammatory pain. Frontiers in Pharmacology. 14: 1171931 |
| Griffett K, Burris TP. (2023) Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases. Frontiers in Medicine. 10: 1102469 |
| Murray MH, Valfort AC, Koelblen T, et al. (2022) Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB. Nature Communications. 13: 7131 |
| Griffett K, Hayes M, Bedia-Diaz G, et al. (2022) Antihyperlipidemic Activity of Gut-Restricted LXR Inverse Agonists. Acs Chemical Biology |
| Welch RD, Billon C, Losby M, et al. (2022) Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH. Metabolites. 12 |
| Griffett K, Hayes ME, Boeckman MP, et al. (2022) The role of REV-ERB in NASH. Acta Pharmacologica Sinica |
| Elgendy B, Griffett K, Hegazy L, et al. (2021) Synthesis and structure activity relationship of the first class of LXR inverse agonists. Bioorganic Chemistry. 119: 105540 |
| Sengupta M, Abuirqeba S, Kameric A, et al. (2021) A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis. Plos One. 16: e0249316 |